Qual é o preço para Recro Pharma, Inc. (REPH)

O preço para Recro Pharma, Inc. (REPH) é $2.09

Qual é a capitalização de mercado para Recro Pharma, Inc. (REPH)

A capitalização de mercado para Recro Pharma, Inc. (REPH) é $47.04M

Histórico de Preços de Recro Pharma, Inc. (REPH)

Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.

Ano	Desempenho
2022	23.15%
2021	-43.90%
2020	-83.97%
2019	139.49%
2018	-25.26%
2017	33.81%
2016	-16.69%
2015	218.14%
2014	0.00%

Ano

Desempenho

2022

23.15%

2021

-43.90%

2020

-83.97%

2019

139.49%

2018

-25.26%

2017

33.81%

2016

-16.69%

2015

218.14%

2014

0.00%

Empresa	Preço da ação	Variação 1a%	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	$171.67	-	DE
Merck KGaA MRK.DE	$163.75	27.60%	DE
Takeda Pharmaceutical Company Limited 4502.T	$37.48	22.66%	JP
Galderma Group AG GALD.SW	$220.05	30.36%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$21.01	11.83%	IN

Empresa

Preço da ação

Variação 1a%

País